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Aachen, GermanyAbstract—Prialt, a synthetic version of Cav2.2 antagonist
x-conotoxin MVIIA derived from Conus magus, is the ﬁrst
clinically approved voltage-gated calcium channel blocker
for refractory chronic pain. However, due to the narrow
therapeutic window and considerable side eﬀects asso-
ciated with systemic dosing, Prialt is only administered
intrathecally. N-triazole oxindole (TROX-1) is a novel use-
dependent and activation state-selective small-molecule
inhibitor of Cav2.1, 2.2 and 2.3 calcium channels designed
to overcome the limitations of Prialt. We have examined
the neurophysiological and behavioral eﬀects of blocking
calcium channels with TROX-1. In vitro, TROX-1, in contrast
to state-independent antagonist Prialt, preferentially inhibits
Cav2.2 currents in rat dorsal root ganglia (DRG) neurons
under depolarized conditions. In vivo electrophysiology
was performed to record from deep dorsal horn lamina
V/VI wide dynamic range neurons in non-sentient spinal
nerve-ligated (SNL) and sham-operated rats. In SNL rats,
spinal neurons exhibited reduced responses to innocuous
and noxious punctate mechanical stimulation of the
receptive ﬁeld following subcutaneous administration of
TROX-1, an eﬀect that was absent in sham-operated ani-
mals. No eﬀect was observed on neuronal responses
evoked by dynamic brushing, heat or cold stimulation in
SNL or sham rats. The wind-up response of spinal neurons
following repeated electrical stimulation of the receptive
ﬁeld was also unaﬀected. Spinally applied TROX-1 dose
dependently inhibited mechanically evoked neuronal
responses in SNL but not sham-operated rats, consistent
with behavioral observations. This study conﬁrms the
pathological state-dependent actions of TROX-1 through a
likely spinal mechanism and reveals a modality selectivehttp://dx.doi.org/10.1016/j.neuroscience.2015.03.057
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INTRODUCTION
Neuropathic pain represents a substantial clinical
challenge with many patients failing to achieve adequate
relief from currently available treatments (Breivik et al.,
2006). Calcium channel modulators are one class of drug
currently used and includes pregabalin and Cav2.2
antagonist Prialt. However, the systemic side eﬀects of
the latter restrict delivery to an intrathecal route in cases
where other treatments have failed.
Calcium inﬂux through voltage-gated calcium
channels (VGCCs) controls a multitude of physiological
processes, including neurotransmitter/hormone release,
membrane excitability, and activation of second
messenger pathways, gene transcription and plasticity.
Cav2.1 (P/Q-type) and Cav2.2 (N-type) channels are
responsible for initiating rapid synaptic transmission. In
the dorsal horn, Cav2.1 and Cav2.2 channels are
present in distinct populations of neurons with the
Cav2.2 channel highly expressed in substance P
positive pre-synaptic terminals of primary aﬀerents
projecting to the superﬁcial laminae (Westenbroek et al.,
1998). Furthermore, Cav2.1 channels, and to a lesser
extent Cav2.2 channels, have been observed in the ven-
tral horn on motor neurons. Cav2.3 (R-type) channels
appear to be predominantly expressed in the soma of dor-
sal horn neurons (Westenbroek et al., 1998). The Cav2
family of channels have been implicated in mediating
the release of several transmitters including dopamine,
glutamate and substance P (Luebke et al., 1993; Turner
et al., 1993; Terashima et al., 2013). In vitro, the release
of CGRP, often co-expressed with substance P, in the
dorsal horn is sensitive to inhibition by x-conotoxin
GVIA (Santicioli et al., 1992). Cav2.2 calcium channels
also mediate the release of noradrenaline from sympa-
thetic neurons and are likely responsible for the potent
hypotensive eﬀect of parenteral x-conotoxin GVIA
(Clasbrummel et al., 1989; Molderings et al., 2000).
Genetic ablation reveals Cav2.2 but not Cav2.3
calcium channels are essential in basal nociception/licenses/by/4.0/).
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et al., 2001; Saegusa et al., 2001), however examining
the role of Cav2.1 channels in nociceptive pathways has
been hampered by the severe neurological deﬁcits and
lethality of a global knockout (Jun et al., 1999). x-cono-
toxin MVIIA and GVIA blockade of Cav2.2 channels is
eﬀective both acutely and in models of neuropathy
(Chaplan et al., 1994; Bowersox et al., 1996; Omote
et al., 1996). Spinally delivered x-agatoxin IVA has no
eﬀect on acute responses to mechanical and thermal
stimulation (Sluka, 1997, 1998), but Cav2.1 channels
may play a more prominent role in the establishment of
a sensitized state and minor eﬀects on the maintenance
(Chaplan et al., 1994; Sluka, 1998; Matthews and
Dickenson, 2001). SNX-482, an antagonist of Cav2.3
channels, exhibits complex pro-nociceptive and anti-
nociceptive eﬀects in the formalin test (Murakami et al.,
2004).
The calcium channel antagonist N-triazole oxindole
(TROX-1) has been shown to inhibit Cav2.1, Cav2.2 and
Cav2.3 VGCCs in a state- and use-dependent manner
(Swensen et al., 2012). We have combined in vitro and
in vivo electrophysiological approaches with behavioral
assays to characterize and relate the cellular,
neurophysiological and behavioral consequences of
blocking calcium channels with TROX-1 to the eﬀects of
a tonic blocker. In vivo electrophysiology, in particular
has been utilized to examine the back-translation of com-
pounds such as pregabalin by recording from deep dorsal
horn neurons in the spinal cord to study spinal processing
of supra-threshold stimuli in uninjured and neuropathic
conditions (Bee and Dickenson, 2008).EXPERIMENTAL PROCEDURES
Animals
Male Sprague–Dawley rats (200–400 g), (from either the
Biological Services Unit (UCL, London, UK) or Janvier,
Le Genest St. Isle, France) were used for behavioral
and in vivo electrophysiological experiments. Animals
were group housed on a 12-h:12-h light–dark cycle;
food and water were available ad libitum. All procedures
described here were licensed by the appropriate
governmental bodies, in compliance with local laws (UK
Animals (Scientiﬁc Procedures) Act 1986 and the
European Communities Council Directive of 24
November 1986 (86/609/EEC)), and were designed to
reduce numbers and undue suﬀering in accordance with
IASP ethics guidelines (Zimmermann, 1983).Spinal nerve ligation (SNL) surgery
SNL surgery was performed as described by Kim and
Chung (1992). For rats intended for in vivo electrophys-
iology studies, surgery was performed under 2% v/v
isoﬂuorane anesthesia delivered in a 3:2 ratio of nitrous
oxide and oxygen. For rats intended for behavioral stud-
ies, surgery was performed under pentobarbital anesthe-
sia (Narcoren, 60 mg/kg intraperitoneally). Under aseptic
conditions a paraspinal incision was made and the left tail
muscle excised. Part of the L5 transverse process wasremoved to expose the L5 and L6 spinal nerves, which
were then isolated with a glass nerve hook (Ski-Ry Ltd,
London, UK) and ligated with a non-absorbable 6-0
braided silk thread proximal to the formation of the sciatic
nerve. The surrounding muscle and skin was closed with
absorbable 3-0 sutures. Sham surgery was performed in
an identical manner omitting the ligation step.Behavioral testing
For the assessment of mechanical hypersensitivity, rats
were placed on a metal mesh covered with a plastic
dome and were allowed to habituate until exploratory
behavior ceased. The threshold for mechanical
hypersensitivity was determined with an electronic von
Frey anesthesiometer (Somedic AB, Malmo¨, Sweden)
using the median of ﬁve consecutive measurements
(inter-measurement interval 1–2 min). Animals with
ipsilateral withdrawal thresholds >30 g and/or
contralateral withdrawal thresholds <50 g were
excluded from the experiment as they did not develop a
tactile hypersensitivity (on average 1/12 animals is
excluded). Animals were tested before and 0.5, 1, and
3 h after administration of the test compounds
(intrathecal Prialt (x-conotoxin MVIIA, Bachem AG,
Bubendorf, Switzerland) dissolved in 0.9% saline, 5-ll
dose; intrathecal racemic TROX-1 ((3R)-5-(3-chloro-4-
ﬂuorophenyl)-3-methyl-3-(pyrimidin-5-ylmethyl)-1-(1H-1,2,
4-triazol-3-yl)-1,3-dihydro-2H-indol-2-one) (synthesized in
house; Gru¨nenthal GmbH, Germany), 5-ll dose;
subcutaneous TROX-1 (5 ml/kg), dissolved in 10%
dimethylsulfoxide (DMSO), 5% cremophor and 5%
glucose solution). Intrathecal dosing was performed as
previously described (Mestre et al., 1994). Drugs or vehi-
cle were tested 2–5 weeks after surgery (one test per
week) in a counterbalanced within-group design.
Animals were randomly assigned to sham or SNL groups
and to treatment conditions. Behavioral testing was per-
formed with the experimenter blinded to the treatment
conditions.In vitro electrophysiology
Cryopreserved neonatal (P2-3) rat dorsal root ganglia
(DRG) were obtained from Lonza Group Ltd, Cologne,
Germany. After thawing a vial of cells at 37 C the cells
were mixed drop-wise with 7.75 ml of pre-warmed
(37 C) Medium A (Primary Neuron Basal Medium
200 ml, Glutamin 2 ml, Gentamycin/Amphotericin 0.2 ml,
NSF-1 4 ml) over a 2-min time frame. Cells were then
transferred to Poly-D-Lysin/Laminin coverslips and
incubated at 37 C, 5% CO2, 95% humidity for 4 h.
Afterward Medium A was replaced with 90 % Medium B
(Medium A, FUDR 5 lg/ml, UDR 5 lg/ml) and cells
were incubated for 4–7 days until use. Medium B was
changed to 50 % every 3 days.
Whole-cell patch-clamp experiments were carried out
with a HEKA EPC 10 patch-clamp ampliﬁer (HEKA
Elektronik Dr. Schulze GmbH, Germany). Borosilicate
patch electrodes with resistances from 3 to 5 MX were
used when ﬁlled with internal solution containing (in
mM): 130 CsCI, 2.7 MgCI2, 9 EGTA, 9 HEPES, 4
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adjusted with CsOH. The extracellular solution contained
(in mM) 150 TEA-Cl, 5 CaCl2, 0.5 MgCI2, 10 HEPES and
10 glucose. The pH was adjusted to 7.3 with TEA-OH.
DRG neurons were voltage clamped at a holding
membrane potential of 90 mV for closed state or at
50 mV for inactivated state experiments. The voltage-
clamp protocol consisted of a 100 ms pre-pulse to
50 mV to inactivate T-type channels followed by a
50 ms step to +10 mV. Sweeps were repeated once
every 15 s and were run continuously to activate Cav2.2
channels. All currents were leak subtracted using a
standard subtraction protocol. After a stable Ca2+
current was obtained, DRG neurons were superfused
with 100 nM isradipine, 300 nM agatoxin IVA, and
150 nM SNX-482 to minimize the contribution of other
non-N-type calcium channels during the whole
experiment. Compounds were directly applied to the cell
by a multi-valve perfusion system (ALA Scientiﬁc
Instruments, Farmingdale, NY, USA) until steady-state
block was achieved. Prialt (x-conotoxin MVIIA, Bachem
AG, Bubendorf, Switzerland) and TROX-1 (Gru¨nenthal
GmbH, Germany) was ﬁrst dissolved in saline (0.9%
NaCl) or 100% DMSO, respectively, and then adjusted
to a ﬁnal concentration lower than 0.3% DMSO.
In vivo electrophysiology
In vivo electrophysiology was conducted as previously
described (Urch and Dickenson, 2003). Spinal
nerve-ligated rats were used between days 15 and 18-
post surgery. Animals were anesthetized with 3.5% v/v
isoﬂuorane delivered in a 3:2 ratio of nitrous oxide and
oxygen. Once areﬂexic, a tracheotomy was performed
and rats were subsequently maintained on 1.5% v/v
isoﬂuorane for the remainder of the experiment. Rats
were secured in a stereotaxic frame and a laminectomy
was performed to expose L4–L5 segments of the spinal
cord. Extracellular recordings were made from deep dor-
sal horn wide dynamic range (WDR) spinal neurons (lam-
ina V/VI) with receptive ﬁelds on the glabrous skin of the
toes using parylene-coated tungsten electrodes (A-M
Systems, Sequim, WA, USA). Neurons were identiﬁed
as WDR by conﬁrming responses to light brushing of
the receptive ﬁeld, noxious punctate mechanical stim-
ulation and noxious thermal stimulation.
Electrical stimulation of WDR neurons was delivered
transcutaneously via needles inserted into the receptive
ﬁeld. A train of 16 electrical stimuli (2-ms pulses, 0.5 Hz)
was applied at three times the threshold current for C
ﬁber activation. Responses evoked by Ab- (0–20 ms),
Ad- (20–90 ms) and C-ﬁbers (90–350 ms) were
separated and quantiﬁed on the basis of latency.
Neuronal responses occurring after the C-ﬁber latency
band were classed as post-discharge (PD). The input (I)
and the wind-up (WU) were calculated as
Input = (action potentials evoked by ﬁrst pulse)  total
number of pulses (16), wind-up = (total action potentials
after 16 train stimulus)  Input. The receptive ﬁeld was
also stimulated using a range of natural stimuli (brush,
von Frey ﬁlaments – 2, 8, 15, 26 and 60 g and heat –
35, 42, 45 and 48 C) applied over a period of 10 s perstimulus and the evoked response quantiﬁed. The heat
stimulus was applied with a constant water jet onto the
center of the receptive ﬁeld. One hundred microliter
acetone and ethyl chloride (Miller Medical Supplies,
Newport, UK) were applied as an evaporative innocuous
cooling and noxious cooling stimulus respectively (Leith
et al., 2010). Evoked responses to room temperature
water were subtracted from acetone and ethyl chloride-
evoked responses to control for concomitant mechanical
stimulation during application.
Data were captured and analyzed by a Cambridge
Electronic Design 1401 interface coupled to a computer
with Spike 2 software (Cambridge, United Kingdom) with
post-stimulus time histogram and rate functions. After
three consecutive stable baseline responses to natural
stimuli (<10% variation, data were averaged to give
control values), animals were injected subcutaneously
into the contralateral ﬂank with 20 mg/kg TROX-1.
Responses to electrical and natural stimuli were
measured 10, 30 and 50 min post dosing. For spinal
dosing, 0.1, 1 and 10 lg of TROX-1 was cumulatively
applied directly onto the cord in a volume of 50 ll. The
vehicle for spinally applied drug was diluted to <1%
cremophor and <1% DMSO. One neuron was
characterized per rat.Statistics
Statistical analyses were performed using SPSS v22
(IBM, Armonk, NY, USA). Behavioral time courses, and
diﬀerences in mechanical and thermal coding of
neurons were tested using a 2-way repeated measures
(RM) analysis of variance (ANOVA), followed by a
Bonferroni post hoc test for paired comparisons.
Sphericity was tested using Mauchly’s test, the
Greenhouse-Geisser correction was applied if violated.
Dynamic brush, cold stimulation and electrical
parameters were compared with a paired Student’s
t-test or 1-way RM ANOVA, followed by a Bonferroni
post hoc test for paired comparisons.RESULTS
Intrathecal TROX-1 attenuates mechanical
hypersensitivity in spinal nerve-ligated rats
Rats were examined at least 14 days post injury for signs
of behavioral hypersensitivity following sham or SNL
surgery. SNL rats displayed guarding behavior of the
injured ipsilateral hind paw, a feature that was absent
on the uninjured contralateral side and in sham-
operated rats. SNL rats, but not sham, displayed
signiﬁcantly reduced withdrawal thresholds to punctate
mechanical stimulation. Intrathecal TROX-1 (Fig. 1A)
and subcutaneous TROX-1 (Fig. 1B) dose dependently
increased mechanical withdrawal thresholds in SNL rats
(2 way RM ANOVA, P< 0.01). Intrathecal Prialt also
dose dependently increased withdrawal thresholds in
SNL rats (2 way RM ANOVA, P< 0.01) (Fig. 1C),
however, the 31.6-ng dose induced respiratory
depression, ﬂat posture, ptosis and sniﬃng behaviors.
On the nerve-injured side, intrathecal TROX-1 displayed
Fig. 1. TROX-1 and Prialt increase mechanical withdrawal thresholds in spinal nerve-ligated rats. (A) Eﬀect of intrathecal TROX-1 on ipsilateral
withdrawal thresholds. (B) Eﬀect of subcutaneous TROX-1 on ipsilateral withdrawal thresholds. (C) Eﬀect of intrathecal Prialt on ipsilateral
withdrawal thresholds. (D) Eﬀect of intrathecal TROX-1 on contralateral withdrawal thresholds. (E) Eﬀect of subcutaneous TROX-1 on contralateral
withdrawal thresholds. (F) Eﬀect of intrathecal Prialt on contralateral withdrawal thresholds. Asterisks denote statistically signiﬁcant diﬀerence from
vehicle group. Data represent mean ± SEM, n= 10, ⁄P< 0.05.
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TROX-1 had no eﬀect on contralateral withdrawal
thresholds (Fig. 1D), whereas Prialt increased
withdrawal thresholds at the highest dose (Fig. 1F).
Surprisingly, systemically delivered TROX-1 increased
contralateral withdrawal thresholds at the highest dose
tested (Fig. 1E). This could be attributed to non-spinally
mediated eﬀects of TROX-1. No obvious signs of motor
deﬁcits were apparent (Rota-rod, data not shown).
Vehicle treatment had no eﬀect on withdrawal
thresholds in sham or SNL animals (data not shown).TROX-1 exhibits activation state-dependent block of
Cav2.2 calcium channels in rat dorsal root ganglion
neurons in vitro
Electrophysiological experiments were performed to
record Cav2.2 calcium currents in rat DRG neurons.
Cav3 calcium channels were inactivated by voltage pre-
pulses, and Cav2.1, Cav2.3 and Cav1 calcium currents
were blocked by a mixture of pharmacological blockers
(Isradipine (100 nM), Agatoxin (300 nM) and SNX-482
(150 nM)). The remaining calcium current was
anticipated to be carried by Cav2.2 channels and was
challenged with Prialt and TROX-1. The average current
for resting state Cav2.2 currents was 551.7 ± 56.5 pA
and 285.6 ± 40.5 pA for the inactivated state.
In depolarized DRG neurons, the activation state-
dependent blocker TROX-1 exhibited a concentration-
dependent inhibition of Cav2.2 calcium currents, whereas
TROX-1 only induced a weak concentration-dependentblock when channels were in a closed state
(Vh = 90 mV) (Fig. 2A). Under hyperpolarised
conditions, 2 lM TROX-1 inhibited 2.6 ± 4.2 % (Fig. 2B)
of Cav2.2 currents compared to 28.6 ± 1.5 % (Fig. 2C)
under depolarized conditions.
The non-state dependent blocker Prialt induced a
concentration-dependent block of Cav2.2 calcium
channels with a near complete block at both holding
potentials (Fig. 2D). At a holding potential of
Vh = 90 mV a residual calcium current of
46.6 ± 5.43% (54.4% inhibition) was determined with
30 nM Prialt (Fig. 2E). Under depolarized conditions
30 nM Prialt reduced the calcium current
(Vh = 50 mV) to 52.0 ± 13.78% (48% inhibition)
(Fig. 2F).Systemic TROX-1 inhibits neuronal responses to
mechanical stimulation in spinal nerve-ligated rats
In vivo electrophysiology was subsequently performed to
examine the eﬀect of TROX-1 on mechanical and thermal
coding of lamina V/VI spinal neurons under uninjured and
neuropathic conditions. A total of 25 neurons were
characterized, Table 1 summarizes neuronal depths
recorded from and evoked baseline responses. Neurons
were characterized from depths relating to deep dorsal
horn laminae (Watson et al., 2009) and were selected
on the basis of responses to noxious heat, dynamic
brushing and noxious mechanical stimulation. No signiﬁ-
cant diﬀerence was observed in the number of Ab-, Ad-
and C- ﬁber evoked action potentials (APs) or the
Fig. 2. TROX-1 preferentially inhibits Cav2.2 currents in rat dorsal root ganglion neurons under depolarized conditions. Experiments conducted in
the presence of isradipine (100 nM), Agatoxin (300 nM) and SNX-482 (150 nM) to block non-Cav2.2 channels. (A) Eﬀect of TROX-1 on calcium
currents under depolarized and hyperpolarised conditions. Representative traces of the eﬀects of 2 lM TROX-1 on calcium currents under
hyperpolarized (B) and depolarized (C) conditions. (D) Eﬀect of Prialt on calcium currents under depolarized and hyperpolarized conditions.
Representative traces of the eﬀects of 30 nM Prialt on calcium currents under hyperpolarized (E) and depolarized (F) conditions. Data represent
mean ± SEM, n= 4–5. (Ctrl – control).
Table 1. Baseline characterizations of deep dorsal horn wide dynamic
range (WDR) neurons from sham and SNL rats. Range of neuronal
depths recorded from in parentheses. Data represent mean ± SEM.
(APs – action potentials)
Sham n= 11 SNL n= 14
Depth (lm) 773 ± 32.88 616 ± 35.32
(670–910) (490–880)
A threshold (mA) 0.03 ± 0.01 0.06 ± 0.01
C threshold (mA) 0.63 ± 0.17 0.47 ± 0.13
Ab-evoked (APs) 87 ± 10.97 101 ± 8.94
Ad-evoked (APs) 199 ± 25.61 203 ± 15.82
C-evoked (APs) 435 ± 30.65 499 ± 37.25
Post-discharge (APs) 292 ± 45.64 362 ± 46.24
Brush (APs) 445 ± 53.61 477 ± 40.33
2 g (APs) 28 ± 4.31 29 ± 4.77
8 g (APs) 299 ± 49.50 302 ± 29.70
15 g (APs) 575 ± 52.39 627 ± 37.02
26 g (APs) 906 ± 50.63 909 ± 40.27
60 g (APs) 1264 ± 59.62 1203 ± 64.02
35 C (APs) 203 ± 32.84 232 ± 28.63
42 C (APs) 461 ± 61.18 412 ± 43.97
45 C (APs) 676 ± 71.89 595 ± 74.33
48 C (APs) 1151 ± 70.01 1068 ± 46.29
Acetone (APs) 74 ± 16.26 65 ± 15.71
Ethyl chloride (APs) 570 ± 118.25 680 ± 100.73
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(unpaired Student’s t-test). Thermally and mechanically
evoked responses of neurons were also similar between
sham and SNL rats (2 way RM ANOVA, P> 0.05).Following isolation and characterization of single WDR
neurons, rats were dosed subcutaneously with 20 mg/kg
TROX-1. In SNL rats, TROX-1 suppressed mechanical
coding of dorsal horn neurons with signiﬁcantly reduced
neuronal responses to low -threshold and supra-
threshold stimuli (2-Way RM ANOVA P< 0.001,
followed by Bonferroni post hoc test) (Fig. 3A). However,
no eﬀect was observed on mechanical coding in sham-
operated rats (2-Way RM ANOVA P> 0.05) (Fig. 3B).
Neuronal responses to dynamic brushing (paired
Student’s t-test, P> 0.05) (Fig. 3C, D), heat (2-Way RM
ANOVA P> 0.05) (Fig. 3E, F) and cold stimulation
(paired Student’s t-test, P> 0.05) (Fig. 3G, H) were also
unaﬀected in both SNL and sham rats. A train of
electrical stimuli was applied to examine the eﬀect of
TROX-1 on pre- and post-synaptic measures of activity.
The total number of evoked APs attributed to Ab-, Ad-
and C- ﬁbers did not signiﬁcantly diﬀer to baseline in
SNL or sham rats. Indicators of neuronal excitability, I,
WU and PD were also unaﬀected (paired Student’s
t-test, P> 0.05) (Fig. 3I, J). No eﬀect of the high dose of
TROX-1 was observed on any of the neuronal
responses in uninjured sham rats despite the same dose
being highly eﬀective and selective for mechanical yet
not heat-evoked ﬁring after nerve injury.
Spinal dosing replicates systemic eﬀect of TROX-1
on mechanically evoked neuronal responses in
spinal nerve-ligated rats
The mechanism of TROX-1 was further investigated by
examining the cumulative eﬀects of 0.1, 1- and 10-lg
TROX-1 applied directly onto to the spinal cord. Spinal
Fig. 3. Systemic TROX-1 selectively inhibits mechanical coding of dorsal horn lamina V/VI neurons in spinal nerve-ligated rats. Following stable
baseline recordings (<10% variation), SNL (n= 6) or sham (n= 5) rats were dosed subcutaneously with 20 mg/kg TROX-1. Neuronal responses
to punctate mechanical (A, B), dynamic brushing (C, D), heat (E, F), innocuous and noxious cooling (G, H), and electrical stimuli (I, J) were
recorded. For natural stimuli, responses were quantiﬁed over a 10-s period. Following repeated electrical stimulation, action potentials were
separated according to latency: Ab: 0–20 ms, Ad: 20–90 ms, C: 90–350 ms, Post-discharge >350 ms. Input and wind-up calculated as described in
Experimental procedures. Left panels – SNL, right panels – sham). Data displayed as maximum change from baseline. Data represent
mean ± SEM. ⁄P< 0.05, ⁄⁄P< 0.01. I – input, WU – wind-up, PD – post-discharge.
52 R. Patel et al. / Neuroscience 297 (2015) 47–57
Fig. 4. Spinal TROX-1 selectively inhibits mechanical coding of dorsal horn lamina V/VI neurons in spinal nerve-ligated rats. Following stable
baseline recordings (<10% variation), SNL (n= 8) or sham (n= 6) rats were dosed spinally with 0.1, 1 and 10 lg TROX-1 in a volume of 50 ll.
Neuronal responses to punctate mechanical (A, B), dynamic brushing (C, D), heat (E, F), innocuous and noxious cooling (G, H), and electrical
stimuli (I, J) were recorded. For natural stimuli, responses were quantiﬁed over a 10-s period. Following repeated electrical stimulation, action
potentials were separated according to latency: Ab: 0–20 ms, Ad: 20–90 ms, C: 90–350 ms, Post-discharge >350 ms. Input and wind-up calculated
as described in Experimental procedures. Asterisks (⁄) denote signiﬁcant diﬀerences between baseline and 1 lg. (+) denotes signiﬁcant
diﬀerences between baseline and 10 lg. Left panels – SNL, right panels – sham). Data displayed as maximum change from baseline. Data
represent mean ± SEM. ⁄P< 0.05, ⁄⁄P< 0.01. I – input, WU – wind-up, PD – post-discharge.
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to punctate mechanical stimulation of the receptive ﬁeld
in SNL rats (2 way RM ANOVA, P< 0.001) (Fig. 4A)
with no eﬀect observed in sham rats (2-way RM
ANOVA, P> 0.05) (Fig. 4B). As previously observed
through a systemic route of administration, TROX-1 did
not alter evoked responses to brushing (1-way RM
ANOVA P> 0.05) (Fig. 4C, D), heat (2-way
RM ANOVA P> 0.05) (Fig. 4E, F), cold (1-Way RM
ANOVA P> 0.05) (Fig. 4G, H) or electrical stimulation
(1-way RM ANOVA P> 0.05) (Fig. 4I, J) of the
receptive ﬁeld in either conditions.DISCUSSION
This study extends previous observations of the eﬀects of
TROX-1 in nociceptive assays in providing a neuronal
correlate of behavioral responses to threshold and
supra-threshold stimulation in a model of neuropathic
pain. Prialt, unlike TROX-1, displays no preference for
activation state, or frequency-dependent inhibition (Feng
et al., 2003). In vivo, TROX-1 selectively attenuates
mechanical hypersensitivity only after neuropathic injury,
unlike calcium channel toxins.
We have previously examined the eﬀects of
antagonists of the Cav2.2 (x-conotoxin GVIA), Cav2.1
(x-agatoxin IVA) and Cav2.3 (SNX-482) channels on
spinal neuronal activity in nerve-injured and uninjured
conditions. All three antagonists inhibited neuronal
responses to mechanical, heat and electrical stimuli,
including wind-up, in SNL rats to various degrees,
though SNX-482 had minimal eﬀects in sham rats
(Matthews and Dickenson, 2001; Matthews et al., 2007).
The increased potency of x-conotoxin GVIA and SNX-
482, but not x-agatoxin IVA, in SNL rats identiﬁes signiﬁ-
cant neuroplastic changes that modulate Cav2.2 and
Cav2.3 function and/or expression after injury (Matthews
and Dickenson, 2001; Matthews et al., 2007). The anti-
hyperalgesic eﬀect of TROX-1 is absent in Cav2.2 null
mice demonstrating a predominant role of this particular
channel in inﬂammatory heat hyperalgesia (Abbadie
et al., 2010).
We have recorded from WDR lamina V/VI neurons;
the ﬁring patterns of these neurons have been shown to
correlate with intensity and temporal aspects of pain in
animals and human subjects (Coghill et al., 1993;
Sikandar et al., 2013). TROX-1 exhibits pathophysiologi-
cal state-dependent activity and selectively suppresses
mechanical coding of WDR neurons in SNL rats. In vitro,
TROX-1 increasingly inhibits calcium currents following
repeated trains of depolarizations thereby demonstrating
use-dependency (Swensen et al., 2012). In contrast,
TROX-1 had no impact on wind-up potentiation of dorsal
horn neurons following repeated electrical stimulation
in vivo. The nature of this stimulus is more akin to
supra-threshold stimulation and involves synchronized
activation of primary aﬀerent terminals in the receptive
ﬁeld. The discord between the in vitro and in vivo scenar-
ios could be explained by the diﬀering stimulus
parameters (in vitro  20  25 ms pulse, 2 Hz. In vivo –
16  2 ms pulse, 0.5 Hz). Wind-up occurs optimallybetween 0.5 and 2 Hz (Herrero et al., 2000). In this
respect, the stimulus frequencies were relatively
comparable between the two studies. Additionally, the
proportion of channels entering an inactivated state
increases with prolonged stimulus duration (Freeze
et al., 2006). Mechanical stimuli applied for 10 s results
in prolonged depolarizations at threshold levels of inten-
sity and thus, natural stimulation may be more amenable
to inhibition in comparison to a rapid electrical stimulus
in vivo. Also, an important caveat to note is that expres-
sion systems do not fully recreate regulation of channel
function.
Dynamic mechanical and cold allodynia are frequent
features of several neuropathies (Maier et al., 2010), how-
ever brushing- and cooling-evoked neuronal responses
were not inhibited by TROX-1. Surprisingly, heat-evoked
responses were also unaﬀected by TROX-1 given the
anti-nociceptive eﬀects of TROX-1 in inﬂammation-
induced heat hyperalgesia (Abbadie et al., 2010). This
perhaps reﬂects divergent mechanisms between inﬂam-
matory hyperalgesia and nerve injury models. A dif-
ferential regulation of pre-synaptic Cav2.2 function may
underlie the modality-selective actions of TROX-1 in
SNL rats.
Functional diversity of Cav2.2 calcium channels is
achieved through alternate splicing of the C-terminus.
In particular the e37a and e37b variants are highly
expressed in nociceptors and whereas the former is
associated with mechanical and thermal hypersensitivity,
the latter only inﬂuences mechanical hypersensitivity
(Altier et al., 2007). The e37a variant, compared to
e37b, exhibits increased channel open time and inacti-
vates more slowly (Castiglioni et al., 2006). Channels
exhibiting these biophysical properties may be more
favorable for inhibition by a state-dependent antagonist.
However, many thousands of splice variants exist,
which may be diﬀerentially expressed after injury, and
could have modality-selective consequences for sensory
transduction. At the mRNA level, Cav2.2 channels do
not appear up-regulated in DRG neurons following
nerve ligation while some splice variants are down-regu-
lated (Altier et al., 2007). In contrast, an increase in the
immunoreactivity of the pore forming a1B subunit in the
superﬁcial laminae has been reported (Cizkova et al.,
2002). This is likely due to the up-regulation of the
a2d-1 subunit that occurs after nerve injury (Luo et al.,
2001), which is also the molecular target for the anti-hy-
peralgesic eﬀects of the gabapentinoids (Field et al.,
2006; Patel et al., 2013). Elevated levels of the a2d-1
subunit in the central terminals of primary aﬀerent ﬁbers
enhances traﬃcking of channels to synapses in addition
to determining kinetics of transmitter release (Hoppa
et al., 2012). Consistent with this role, synaptosomal
levels of Cav2.2 are reduced in a2d-1 knockout mice
(Patel et al., 2013). Although predominantly expressed
in unmyelinated DRG neurons under normal conditions,
the a2d-1 subunit is up-regulated in neurons of all types
after injury (Bauer et al., 2009). The increase in traﬃck-
ing and inactivation rate of calcium channels by a2d-1
likely enhances pre-synaptic terminal excitability and
facilitates excitatory transmission by supporting rapid
R. Patel et al. / Neuroscience 297 (2015) 47–57 55transition between active and inactive states (Li et al.,
2006). Diﬀerential expression of a2d-1 splice variants
also occurs following SNL, though these variants exert
similar eﬀects on the biophysical properties of Cav2 cur-
rents (Lana et al., 2013). Although not consistently
observed, expression of the b3 subunit may also
increase after nerve injury (Li et al., 2012; Patel et al.,
2013), which could further inﬂuence the rate of channel
activation and inactivation (Castellano et al., 1993),
resulting in enhanced calcium currents in small diameter
DRG neurons (Li et al., 2012). Overall, the magnitudes
of eﬀect for systemic pregabalin and TROX-1, at similar
doses, on lamina V/VI neuronal responses are similar,
although the former additionally inhibited thermal
responses (Bee and Dickenson, 2008).
In addition, descending facilitatory and inhibitory
monoaminergic pathways converging onto the dorsal
horn may also inﬂuence the excitability of pre-synaptic
terminals. Descending serotonergic inhibitory pathways
terminating on metabatropic 5-HTRs can directly, or
indirectly through inhibitory interneurons, exert
inhibitory inﬂuences on pre-synaptic calcium channel
function and subsequent transmitter release (Brenchat
et al., 2010; Choi et al., 2012). G-protein-coupled recep-
tor moderation of primary aﬀerent terminal excitability
could additionally occur through regulation of potassium
currents consequently hyperpolarizing pre-synaptic
terminals (Yagi and Sumino, 1998). Numerous studies
have identiﬁed deﬁcits in inhibitory drive following a
neuropathic injury (Moore et al., 2002; Rahman et al.,
2008; Hughes et al., 2013). Additionally, descending
facilitatory pathways activating ionotropic 5-HT3Rs will
have further depolarizing eﬀects on pre-synaptic term-
inals. Spinally delivered ondansetron, a 5-HT3R antago-
nist, inhibits mechanically evoked responses with
minimal eﬀects on heat-evoked responses in SNL rats
(Suzuki et al., 2004). Spinalization of SNL rats ablates
mechanical hypersensitivity but not heat hypersensitivity
indicating the latter is likely dependent on spinal
disinhibition whereas the former requires intact
spinal-supraspinal circuits (Ossipov et al., 2000). One
possibility is that a combination of neuroplastic changes
in primary aﬀerent excitability coupled with alterations in
activity in descending pathways underlies the patho-
physiological and modality-selective actions of TROX-1
in SNL rats. This would be consistent with eﬃcacy in
the sodium iodoacetate-induced osteoarthritis model
(Abbadie et al., 2010), which can be characterized by
a neuropathic component resulting in hypersensitivity
in areas of the dermatome outside the primary area of
injury (Combe et al., 2004). A time-dependent loss of
noradrenergic inhibition and an increased descending
facilitatory drive has been demonstrated in this model
(Rahman et al., 2009; Burnham and Dickenson, 2013).
Our data suggest spinally expressed calcium
channels are critical for the anti-hyperalgesic eﬀects of
TROX-1. Cav2.2 calcium channels at the site of injury
may contribute to aﬀerent dysfunction, generation of
ectopic discharges and hyperexcitability (Xiao and
Bennett, 1995), though this does not appear consistent
across models (Chaplan et al., 1994). Injection of x-conotoxin GVIA into the central nucleus of the amyg-
dala is pro-nociceptive in the early phase of the formalin
test with no eﬀect on the secondary phase supporting a
role for the central nucleus in tonically inhibiting acute
nociceptive drive (Finn et al., 2003). Intra-rostral ven-
tromedial medulla injections of x-conotoxin MVIIA, but
not x-agatoxin IVA, alleviates mechanical hypersensitiv-
ity following SNL implicating Cav2.2 over Cav2.1 chan-
nels in modulating activity in descending pathways
(Urban et al., 2005). However, the precise mechanism
at this site remains unclear. These ﬁndings do not
entirely preclude non-spinally mediated eﬀects of
TROX-1.
Several clinical trials have been undertaken to
examine eﬃcacy of state-dependent calcium channel
antagonists in chronic pain patients (Clinical Trials
Identiﬁers: NCT01848730, NCT01655849). Compounds
such as TROX-1 have substantial advantages over
peptide antagonists by being orally bioavailable and
blood–brain barrier penetrant. State-dependent channel
antagonists are a promising area for selectively
inhibiting aberrant neuronal activity in neuropathic pain.
From a translational perspective, further pre-clinical
characterizations of the eﬀects on nociceptive
processing may help shape future trials and act as
better predictors for success.FUNDING
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